Surgical targeting through photo-medicine based localization using Luminomark injection for thyroid surgery

Not Applicable

Not yet recruiting

• Conditions: Neoplasms

• Registration Number: KCT0008529
• Lead Sponsor: ational Cancer Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

1. Thyroid nodules or follicular tumors that are difficult to localize with conventional methods such as CT, ultrasound, and scans, but require surgery
2. Recurrent or primary thyroid cancer for which surgery is planned, although localization is difficult with conventional methods such as CT, ultrasound, and scan
3. Parathyroid adenoma or cancer that is difficult to localize with conventional methods such as CT, ultrasound, or scan, but surgery is planned
4. Cervical tumors that are difficult to localize with conventional methods such as CT, ultrasound, and scans, but require surgery
5. Patients between the ages of 19 and 80
6. Patients who voluntarily decided to participate in this clinical study and signed the written informed consent

Exclusion Criteria

1. Those with a history of allergy to ICG (Indocyanine Green)
2. Pregnant and lactating women
3. Women of childbearing potential who are expected to become pregnant (menopausal women with at least 12 months of amenorrhea are considered non-fertile women)
4. Patients with mental illness, those with a history of alcoholism or drug abuse
5. Those who have participated in other clinical trials within 6 months of participating in this study
6. A person who is judged by the researcher to be unfit to participate in the research for other reasons
7. Patients with a history of hypersensitivity to active ingredients and excipients of investigational drugs

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the success rate of topical labeling.

Secondary Outcome Measures

Name	Time	Method
Evaluate the time required to excise the first target lesion, evaluate the total lesion excision surgery time, evaluate the pigmentation rate, evaluate the rate of postoperative side effects, evaluate safety data (vital signs, adverse events)